Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1

Circulation Research

Volumn 88, Issue 6, 2001, Pages 609-614

  Yamashita, Kazuhito ^a,b   Kajstura, Jan ^a,b   Discher, Daryl J ^a,b   Wasserlauf, Bernard J ^a,b   Bishopric, Nanette H ^a,b   Anversa, Piero ^a,b   Webster, Keith A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Hypoxia; Ischemia; p38 mitogen activated protein kinase; Phosphoinositol 3 kinase; SB203580

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; PROTEIN KINASE B; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE REPERFUSION; HYPOXIA; ISCHEMIA; ISOLATED HEART; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0035970539     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.88.6.609     Document Type: Article

References (39)

1. Insulin-like growth factor improves recovery of cardiac performance during reperfusion in isolated rat heart by a wortmannin-sensitive mechanism
2. Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion
3. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy
4. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
5. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor
6. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro
7. Signaling through lipid products of phosphinositide-3′-OH kinase
8. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
9. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
10. Regulation of cell death protease caspase-9 by phosphorylation
11. Akt promotes cell survival by phosphorylating and inhibiting Forkhead transcription factor
12. Insulin-like growth factor-1 attenuates the detrimental impact of non-occlusive coronary artery constriction on the heart
13. Changes in IGFs in cardiac tissue following myocardial infarction
14. Changes of the insulin-like growth factor 1 system during acute myocardial infarction: Implications on left ventricular remodeling
15. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration
16. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice
17. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53
18. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x
19. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II dependent
20. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes
21. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-acfivated protein kinase-dependent manner
22. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
23. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
24. Inhibition of extracellular signal-regulated kinase enhances ischemia/reperfusion-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart
25. PI3K. Downstream AKTion blocks apoptosis
26. Mechanism of activation of protein kinase B by insulin and IGF-1
27. Stimulation of the stress-activated mitogen-activated protein kinases are activated by ischemia/reperfusion
28. "Stress-responsive" mitogen-activated protein kinases in the myocardium
29. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
30. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase
31. Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes
32. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase
33. Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes
34. Stimulation of stress-regulated mitogen-activated protein kinases (stress-activated protein kinases/c-Jun-N-terminal kinases and p39-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses
35. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death
36. Inhibition of p38α activation may underlay protection in a surrogate model of ischemic preconditioning
37. Molecular switches for regulating therapeutic genes
38. Regulated expression of a foreign gene targeted to the ischemic myocardium
39. Conditional silencing as a means to suppress basal expression and augment the "therapeutic differential" of gene therapy vectors targeted to ischemic tissues